LC-MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma.

MLA

Xiaoyan Liu, et al. “LC-MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma.” Frontiers in Oncology, vol. 12, July 2022, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fonc.2022.949513.

APA

Xiaoyan Liu, Jing Li, Xiaolei Hao, Haidan Sun, Yang Zhang, Liwei Zhang, Lulu Jia, Yongji Tian, & Wei Sun. (2022). LC-MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma. Frontiers in Oncology, 12, 1–9. https://doi.org/10.3389/fonc.2022.949513

Chicago

Xiaoyan Liu, Jing Li, Xiaolei Hao, Haidan Sun, Yang Zhang, Liwei Zhang, Lulu Jia, Yongji Tian, and Wei Sun. 2022. “LC-MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma.” Frontiers in Oncology 12 (July): 1–9. doi:10.3389/fonc.2022.949513.